American businesses under attack in Biden's bizarro world

FTC officials are collaborating with Europeans to foil U.S. health care company acquisition of a startup focused on early cancer detection.

Except, incredibly, that’s exactly what’s happening in the bizarro world of today’s Federal Trade Commission (FTC).

In February, the Wall Street Journal reported that FTC officials are collaborating with European counterparts to foil U.S. health care company Illumina’s acquisition of Grail, a startup focused on early cancer detection. Emails recovered through a U.S. Chamber of Commerce FOIA request show the FTC secretly coordinating with European officials to scuttle the deal.